CSIMarket
 
Neubase Therapeutics inc   (NBSE)
 

The company reported operating deficit of $-8.654093 million, in the Sep 30 2022 report

recorded fourth quarter of 2022 operating deficit of $-8.654093 million


Published Dec 22 2022
CSIMarket Team / CSIMarket.com


Dryvax_pd The Major Pharmaceutical Preparations industry observers begin to analyze the fourth quarter of 2022 numbers. Today those observers observe operating deficit of $-8.654093 million, from the company, as it has not specified any revenue so far, for the respective July to September 30 2022 quarter.

The rising company has not declared the revenue so far, but to place recent effort into a frame of reference. That is supported by measuring with corporate achievement through the fourth quarter of 2021, where the company realized an operating deficit of $-5.895769 million.


On the quest to prompt a lucrative business strategy, businesses often undergo uncommonly rough period. One of this, was the most recent fiscal period, where the net loss has swelled to $-9.668 million.

announced loss of $-33.78 million and revenues of $0.00 million in the fiscal year 2022.

Net loss per share has widen to $-1.04 from $-0.93 in the previous fiscal year, while by 0 % from $0.00 million a year ago.

Neubase Therapeutics Inc is expected to report next financial earnings on May 11, 2023.



Neubase Therapeutics Inc's Price to Cash Flow ratio

Neubase Therapeutics Inc's Operating Margin



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com